Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Celiac Disease More Prevalent in Patients With Juvenile Idiopathic Arthritis
April 26th 2022“Understanding the extent of the co-occurrence and identifying factors associated with an increased susceptibility could be relevant to implement case-finding strategies in specific at-risk populations," investigators stated.
Read More
Strict Treat-to-Target Approach Beneficial for Patients With RA
April 18th 2022White a treat-to-target strategy is an important part of managing patients with rheumatoid arthritis, a more controlled implementation with closer follow-up appointments and patient education yielded better outcomes.
Read More
Poor Treatment Response Linked to Residual Disease in Patients with PsA
April 14th 2022“Although the achievement of treatment targets has been associated with improved quality of life and slower disease progression, patients may still experience symptoms and a burden of disease,” investigators stated.
Read More
Jeff Peterson, MD: FDA Announces Priority Review of Pegloticase Plus Methotrexate for Gout Treatment
April 5th 2022Jeff Peterson, MD, explains the importance of the recent FDA announcement granting priority review of the Supplemental Biologics License Application for concomitant use of pegloticase injection (KRYSTEXXA) plus methotrexate for patients with uncontrolled gout.
Read More